Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,277) with videos related to
Page
of 128
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein
Craig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, et al.
Journal for Immunotherapy of Cancer
|
January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Atara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
Journal of Neuroendocrinology
|
May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force
Anna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Theranostics
|
October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers
Andrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, R J Lee, et al.
Journal of Medical Genetics
|
September 12, 2018
Bayesian approach to determining penetrance of pathogenic SDH variants
Diana E Benn, Ying Zhu, Katrina A Andrews, et al.
Plos One
|
May 20, 2021
Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study
Nicholette D Palmer, Lingyi Lu, Thomas C Register, et al.
Journal of Neuroendocrinology
|
December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Nature Communications
|
March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanoma
Lorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Page
of 128
Search research articles
Search
Showing results (1211-1220 of 1,277) with videos related to
Sort By:
Page
of 128
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein
Craig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, et al.
Journal for Immunotherapy of Cancer
|
January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Atara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
Journal of Neuroendocrinology
|
May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force
Anna Koumarianou, Pier Luigi Filosso, Lisa Bodei, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Theranostics
|
October 14, 2020
First clinical study of a pegylated diabody <sup>124</sup>I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers
Andrew M Scott, Timothy Akhurst, Fook-Thean Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, R J Lee, et al.
Journal of Medical Genetics
|
September 12, 2018
Bayesian approach to determining penetrance of pathogenic SDH variants
Diana E Benn, Ying Zhu, Katrina A Andrews, et al.
Plos One
|
May 20, 2021
Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study
Nicholette D Palmer, Lingyi Lu, Thomas C Register, et al.
Journal of Neuroendocrinology
|
December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Nature Communications
|
March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanoma
Lorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Page
of 128